{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T13:31:54Z","timestamp":1789997514923,"version":"4.0.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T00:00:00Z","timestamp":1762905600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T00:00:00Z","timestamp":1762905600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"National Key Research and Development Program of China","award":["2022YFC2703800"],"award-info":[{"award-number":["2022YFC2703800"]}]},{"DOI":"10.13039\/100016692","name":"Key Research and Development Program of Ningxia","doi-asserted-by":"publisher","award":["2023BEG01001"],"award-info":[{"award-number":["2023BEG01001"]}],"id":[{"id":"10.13039\/100016692","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Ovarian Res"],"DOI":"10.1186\/s13048-025-01819-8","type":"journal-article","created":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T14:21:20Z","timestamp":1762957280000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Tumor recurrence risk following different COS regimens in infertile women with borderline ovarian tumors: impact on IVF outcomes"],"prefix":"10.1186","volume":"18","author":[{"given":"Liang","family":"Liang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiu-Mei","family":"Zhen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue-Ling","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,12]]},"reference":[{"key":"1819_CR1","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s00428-016-2040-8","volume":"470","author":"S Hauptmann","year":"2017","unstructured":"Hauptmann S, Friedrich K, Redline R, Avril S. Ovarian borderline tumors in the 2014 WHO classification: evolving concepts and diagnostic criteria. Virchows Arch. 2017;470:125\u201342.","journal-title":"Virchows Arch"},{"key":"1819_CR2","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.ctrv.2016.06.010","volume":"49","author":"G Mangili","year":"2016","unstructured":"Mangili G, Somigliana E, Giorgione V, Martinelli F, Filippi F, Petrella MC, et al. Fertility preservation in women with borderline ovarian tumours. Cancer Treat Rev. 2016;49:13\u201324.","journal-title":"Cancer Treat Rev"},{"key":"1819_CR3","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1093\/humupd\/dms047","volume":"19","author":"E Darai","year":"2013","unstructured":"Darai E, Fauvet R, Uzan C, Gouy S, Duvillard P, Morice P. Fertility and borderline ovarian tumor: a systematic review of Conservative management, risk of recurrence and alternative options. Hum Reprod Update. 2013;19:151\u201366.","journal-title":"Hum Reprod Update"},{"key":"1819_CR4","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.ejca.2019.04.018","volume":"116","author":"C Rousset-Jablonski","year":"2019","unstructured":"Rousset-Jablonski C, Selle F, Adda-Herzog E, Planchamp F, Selleret L, Pomel C, et al. Fertility preservation, contraception and menopause hormone therapy in women treated for rare ovarian tumours: guidelines from the French National network dedicated to rare gynaecological cancers. Eur J Cancer. 2019;116:35\u201344.","journal-title":"Eur J Cancer"},{"key":"1819_CR5","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1097\/IGC.0000000000000782","volume":"26","author":"E Vancraeynest","year":"2016","unstructured":"Vancraeynest E, Moerman P, Leunen K, Amant F, Neven P, Vergote I. Fertility preservation is safe for serous borderline ovarian tumors. Int J Gynecol Cancer. 2016;26:1399\u2013406.","journal-title":"Int J Gynecol Cancer"},{"key":"1819_CR6","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.ygyno.2019.12.046","volume":"157","author":"A Chevrot","year":"2020","unstructured":"Chevrot A, Pouget N, Bats AS, Huchon C, Guyon F, Chopin N, et al. Fertility and prognosis of borderline ovarian tumor after Conservative management: results of the multicentric OPTIBOT study by the GINECO & TMRG group. Gynecol Oncol. 2020;157:29\u201335.","journal-title":"Gynecol Oncol"},{"key":"1819_CR7","first-page":"330","volume":"48","author":"J Raad","year":"2020","unstructured":"Raad J, Rolland L, Grynberg M, Courbiere B, Mathieu d\u2019Argent E. [Borderline ovarian tumours: CNGOF guidelines for clinical Practice - Fertility]. Gynecol Obstet Fertil Senol. 2020;48:330\u20136.","journal-title":"Gynecol Obstet Fertil Senol"},{"key":"1819_CR8","doi-asserted-by":"publisher","first-page":"101966","DOI":"10.1016\/j.jogoh.2020.101966","volume":"50","author":"N Bourdel","year":"2021","unstructured":"Bourdel N, Huchon C, Abdel Wahab C, Aza\u00efs H, Bendifallah S, Bolze PA, et al. Borderline ovarian tumors: French guidelines from the CNGOF. Part 2. Surgical management, follow-up, hormone replacement therapy, fertility management and preservation. J Gynecol Obstet Hum Reprod. 2021;50:101966.","journal-title":"J Gynecol Obstet Hum Reprod"},{"key":"1819_CR9","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.ygyno.2012.10.013","volume":"128","author":"J Escobar","year":"2013","unstructured":"Escobar J, Klimowicz AC, Dean M, Chu P, Nation JG, Nelson GS, et al. Quantification of ER\/PR expression in ovarian low-grade serous carcinoma. Gynecol Oncol. 2013;128:371\u20136.","journal-title":"Gynecol Oncol"},{"key":"1819_CR10","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1007\/s00404-010-1804-7","volume":"284","author":"M Kanat-Pektas","year":"2011","unstructured":"Kanat-Pektas M, Ozat M, Gungor T, Dikici T, Yilmaz B, Mollamahmutoglu L. Fertility outcome after Conservative surgery for borderline ovarian tumors: a single center experience. Arch Gynecol Obstet. 2011;284:1253\u20138.","journal-title":"Arch Gynecol Obstet"},{"key":"1819_CR11","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1159\/000497203","volume":"84","author":"S Li","year":"2019","unstructured":"Li S, Lin H, Xie Y, Jiao X, Qiu Q, Zhang Q. Live births after in vitro fertilization with Fertility-Sparing surgery for borderline ovarian tumors: A case series and literature review. Gynecol Obstet Invest. 2019;84:445\u201354.","journal-title":"Gynecol Obstet Invest"},{"key":"1819_CR12","unstructured":"Du Bois A, Ewaldriegler N, Du Bois O, Harter P. Borderline tumors of the ovary: a systematic review 2009."},{"issue":"09","key":"1819_CR13","first-page":"898","volume":"44","author":"H Zhang","year":"2024","unstructured":"Zhang H, Yang S, Tian T, Zhen X. Effect of the duration of gonadotropin stimulation on pregnancy outcome of in vitro fertilization and embryo transfer with GnRH-a long protocol. Chin J Reprod Contracept. 2024;44(09):898\u2013905.","journal-title":"Chin J Reprod Contracept"},{"key":"1819_CR14","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.ejca.2019.01.021","volume":"111","author":"M Delle Marchette","year":"2019","unstructured":"Delle Marchette M, Ceppi L, Andreano A, Bonazzi CM, Buda A, Grassi T, et al. Oncologic and fertility impact of surgical approach for borderline ovarian tumours treated with fertility sparing surgery. Eur J Cancer. 2019;111:61\u20138.","journal-title":"Eur J Cancer"},{"key":"1819_CR15","doi-asserted-by":"publisher","first-page":"2712","DOI":"10.1093\/humrep\/des195","volume":"27","author":"F Raffi","year":"2012","unstructured":"Raffi F, Shaw RW, Amer SA. National survey of the current management of endometriomas in women undergoing assisted reproductive treatment. Hum Reprod. 2012;27:2712\u20139.","journal-title":"Hum Reprod"},{"key":"1819_CR16","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1093\/humupd\/dmaa035","volume":"27","author":"AK Datta","year":"2021","unstructured":"Datta AK, Maheshwari A, Felix N, Campbell S, Nargund G. Mild versus conventional ovarian stimulation for IVF in poor, normal and hyper-responders: a systematic review and meta-analysis. Hum Reprod Update. 2021;27:229\u201353.","journal-title":"Hum Reprod Update"},{"key":"1819_CR17","doi-asserted-by":"publisher","first-page":"5275","DOI":"10.7150\/jca.56387","volume":"12","author":"Y Qi","year":"2021","unstructured":"Qi Y, Wang M, Yang Y, Zeng Z, Zhou Y. Analysis of factors influencing relapse and pregnancy in patients with borderline ovarian tumors. J Cancer. 2021;12:5275\u201385.","journal-title":"J Cancer"},{"key":"1819_CR18","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.tjog.2016.04.005","volume":"55","author":"Y Huang","year":"2016","unstructured":"Huang Y, Zhang W, Wang Y. The feasibility of fertility-sparing surgery in treating advanced-stage borderline ovarian tumors: A meta-analysis. Taiwan J Obstet Gynecol. 2016;55:319\u201325.","journal-title":"Taiwan J Obstet Gynecol"},{"key":"1819_CR19","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1159\/000316264","volume":"70","author":"D Denschlag","year":"2010","unstructured":"Denschlag D, von Wolff M, Amant F, Kesic V, Reed N, Schneider A, et al. Clinical recommendation on fertility preservation in borderline ovarian neoplasm: ovarian stimulation and oocyte retrieval after Conservative surgery. Gynecol Obstet Invest. 2010;70:160\u20135.","journal-title":"Gynecol Obstet Invest"},{"key":"1819_CR20","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1016\/j.ygyno.2019.09.012","volume":"155","author":"E Taylan","year":"2019","unstructured":"Taylan E, Oktay K. Fertility preservation in gynecologic cancers. Gynecol Oncol. 2019;155:522\u20139.","journal-title":"Gynecol Oncol"},{"key":"1819_CR21","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1002\/cncr.20098","volume":"100","author":"R Fauvet","year":"2004","unstructured":"Fauvet R, Boccara J, Dufournet C, David-Montefiore E, Poncelet C, Dara\u00ef E. Restaging surgery for women with borderline ovarian tumors: results of a French multicenter study. Cancer. 2004;100:1145\u201351.","journal-title":"Cancer"},{"key":"1819_CR22","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.beem.2018.10.002","volume":"33","author":"AM Quaas","year":"2019","unstructured":"Quaas AM, Legro RS. Pharmacology of medications used for ovarian stimulation. Best Pract Res Clin Endocrinol Metab. 2019;33:21\u201333.","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"1819_CR23","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1093\/humrep\/dew242","volume":"31","author":"C van Tilborg","year":"2016","unstructured":"van Tilborg C, Oudshoorn SC, Eijkemans MJC, Manger PAP, Brinkhuis E, van Heusden AM, et al. Optimization of outcome through individualized dosing in predicted poor responders undergoing IVF\/ICSI; the OPTIMIST randomized controlled trial, NTR2657. Hum Reprod. 2016;31:16\u20137.","journal-title":"Hum Reprod"},{"key":"1819_CR24","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.ejogrb.2020.07.053","volume":"253","author":"S Khiat","year":"2020","unstructured":"Khiat S, Provansal M, Bottin P, Saias-Magnan J, Metzler-Guillemain C, Courbiere B. Fertility preservation after fertility-sparing surgery in women with borderline ovarian tumours. Eur J Obstet Gynecol Reprod Biol. 2020;253:65\u201370.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"1819_CR25","doi-asserted-by":"publisher","first-page":"2222","DOI":"10.1093\/humrep\/dey321","volume":"33","author":"A Cobo","year":"2018","unstructured":"Cobo A, Garc\u00eda-Velasco J, Domingo J, Pellicer A, Remoh\u00ed J. Elective and Onco-fertility preservation: factors related to IVF outcomes. Hum Reprod. 2018;33:2222\u201331.","journal-title":"Hum Reprod"}],"container-title":["Journal of Ovarian Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-025-01819-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13048-025-01819-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-025-01819-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T14:21:22Z","timestamp":1762957282000},"score":1,"resource":{"primary":{"URL":"https:\/\/ovarianresearch.biomedcentral.com\/articles\/10.1186\/s13048-025-01819-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,12]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1819"],"URL":"https:\/\/doi.org\/10.1186\/s13048-025-01819-8","relation":{},"ISSN":["1757-2215"],"issn-type":[{"value":"1757-2215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,12]]},"assertion":[{"value":"12 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki and was approved by the ethics committee of the Peking University Third Hospital(2019SZ018). Informed patient consent was not required as the study was retrospective in nature and analyzed patient data anonymously. A statement from the ethics committee of the Peking University Third Hospital waived the need for informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human ethics and consent to participate declarations"}},{"value":"Not Applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}},{"value":"None.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Prior Presentation"}}],"article-number":"253"}}